rs201190805

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_024570.4(RNASEH2B):​c.868G>A​(p.Asp290Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000387 in 1,603,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D290D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00040 ( 0 hom. )

Consequence

RNASEH2B
NM_024570.4 missense

Scores

5
11
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 7.28

Publications

4 publications found
Variant links:
Genes affected
RNASEH2B (HGNC:25671): (ribonuclease H2 subunit B) RNase H2 is composed of a single catalytic subunit (A) and two non-catalytic subunits (B and C) and specifically degrades the RNA of RNA:DNA hybrids. The protein encoded by this gene is the non-catalytic B subunit of RNase H2, which is thought to play a role in DNA replication. Multiple transcript variants encoding different isoforms have been found for this gene. Defects in this gene are a cause of Aicardi-Goutieres syndrome type 2 (AGS2). [provided by RefSeq, Nov 2008]
RNASEH2B Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Aicardi-Goutieres syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15267545).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNASEH2BNM_024570.4 linkc.868G>A p.Asp290Asn missense_variant Exon 11 of 11 ENST00000336617.8 NP_078846.2 Q5TBB1-1Q8N451

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNASEH2BENST00000336617.8 linkc.868G>A p.Asp290Asn missense_variant Exon 11 of 11 1 NM_024570.4 ENSP00000337623.2 Q5TBB1-1

Frequencies

GnomAD3 genomes
AF:
0.000263
AC:
40
AN:
152010
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00123
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000432
AC:
102
AN:
236218
AF XY:
0.000407
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000148
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00128
Gnomad NFE exome
AF:
0.000663
Gnomad OTH exome
AF:
0.000171
GnomAD4 exome
AF:
0.000400
AC:
580
AN:
1451200
Hom.:
0
Cov.:
30
AF XY:
0.000385
AC XY:
278
AN XY:
721248
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33212
American (AMR)
AF:
0.000204
AC:
9
AN:
44102
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25732
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39466
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85154
European-Finnish (FIN)
AF:
0.00121
AC:
64
AN:
52738
Middle Eastern (MID)
AF:
0.000348
AC:
2
AN:
5744
European-Non Finnish (NFE)
AF:
0.000432
AC:
477
AN:
1105196
Other (OTH)
AF:
0.000451
AC:
27
AN:
59856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
29
59
88
118
147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000263
AC:
40
AN:
152128
Hom.:
0
Cov.:
32
AF XY:
0.000350
AC XY:
26
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41500
American (AMR)
AF:
0.000196
AC:
3
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00123
AC:
13
AN:
10568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68000
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000440
Hom.:
0
Bravo
AF:
0.000287
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000487
AC:
59

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Aicardi-Goutieres syndrome 2 Uncertain:2
Oct 31, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 290 of the RNASEH2B protein (p.Asp290Asn). This variant is present in population databases (rs201190805, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with RNASEH2B-related conditions. ClinVar contains an entry for this variant (Variation ID: 586407). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RNASEH2B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Dec 21, 2023
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Nov 28, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Uncertain
-0.020
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.60
D;.;.;.;.;.;.;.;T;T
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.95
D;D;D;D;D;D;D;T;.;D
M_CAP
Pathogenic
0.34
D
MetaRNN
Benign
0.15
T;T;T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
0.87
D
MutationAssessor
Uncertain
2.8
M;.;.;.;.;.;.;.;.;.
PhyloP100
7.3
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-2.8
D;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.64
Sift
Uncertain
0.010
D;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
0.023
D;.;.;.;.;.;.;.;.;.
Polyphen
1.0
D;.;.;.;.;.;.;.;.;.
Vest4
0.47
MVP
0.98
MPC
0.31
ClinPred
0.25
T
GERP RS
6.1
Varity_R
0.64
gMVP
0.34
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201190805; hg19: chr13-51530539; API